|
Originally published In Press as doi:10.1074/jbc.M210241200 on July 17, 2003
J. Biol. Chem., Vol. 278, Issue 42, 41141-41147, October 17, 2003
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products*
Yvain Nicolet ,
Oksana Lockridge ¶,
Patrick Masson ||,
Juan C. Fontecilla-Camps ** and
Florian Nachon ¶ ||
From the
Laboratoire de Cristallographie et Cristallogénèse des Protéines, Institut de Biologie Structurale "Jean-Pierre Ebel," CEA, UJF, CNRS, 41 rue Jules Horowitz, 38027 Grenoble Cedex 1, France, the ¶University of Nebraska Medical Center, Eppley Research Institute, Omaha, NE 68198-6805, and the ||Centre de Recherches du Service de Santé des Armées, Unité d'Enzymologie, 24 Avenue des Maquis du Grésivaudan, BP 87-38702 La Tronche CEDEX, France
Cholinesterases are among the most efficient enzymes known. They are divided into two groups: acetylcholinesterase, involved in the hydrolysis of the neurotransmitter acetylcholine, and butyrylcholinesterase of unknown function. Several crystal structures of the former have shown that the active site is located at the bottom of a deep and narrow gorge, raising the question of how substrate and products enter and leave. Human butyrylcholinesterase (BChE) has attracted attention because it can hydrolyze toxic esters such as cocaine or scavenge organophosphorus pesticides and nerve agents. Here we report the crystal structures of several recombinant truncated human BChE complexes and conjugates and provide a description for mechanistically relevant non-productive substrate and product binding. As expected, the structure of BChE is similar to a previously published theoretical model of this enzyme and to the structure of Torpedo acetylcholinesterase. The main difference between the experimentally determined BChE structure and its model is found at the acyl binding pocket that is significantly bigger than expected. An electron density peak close to the catalytic Ser198 has been modeled as bound butyrate.
Received for publication, October 7, 2002
, and in revised form, July 2, 2003.
The atomic coordinates and structure factors (code P0I, 1P0Q, 1P0M, and 1P0P) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Chemistry, Massachusetts Inst. of Technology, Cambridge, MA 02139.
** To whom correspondence should be addressed. Tel.: 33-438785920; Fax: 33-438785122; E-mail: juan{at}lccp.ibs.fr.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Podoly, D. E. Shalev, S. Shenhar-Tsarfaty, E. R. Bennett, E. Ben Assayag, H. Wilgus, O. Livnah, and H. Soreq
The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology{diamondsuit}
J. Biol. Chem.,
June 19, 2009;
284(25):
17170 - 17179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Colletier, D. Bourgeois, B. Sanson, D. Fournier, J. L. Sussman, I. Silman, and M. Weik
Shoot-and-Trap: Use of specific x-ray damage to study structural protein dynamics by temperature-controlled cryo-crystallography
PNAS,
August 19, 2008;
105(33):
11742 - 11747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Groner, Y. Ashani, D. Schorer-Apelbaum, J. Sterling, Y. Herzig, and M. Weinstock
The Kinetics of Inhibition of Human Acetylcholinesterase and Butyrylcholinesterase by Two Series of Novel Carbamates
Mol. Pharmacol.,
June 1, 2007;
71(6):
1610 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bourne, Z. Radic, G. Sulzenbacher, E. Kim, P. Taylor, and P. Marchot
Substrate and Product Trafficking through the Active Center Gorge of Acetylcholinesterase Analyzed by Crystallography and Equilibrium Binding
J. Biol. Chem.,
September 29, 2006;
281(39):
29256 - 29267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. De Jaco, D. Comoletti, Z. Kovarik, G. Gaietta, Z. Radic, O. Lockridge, M. H. Ellisman, and P. Taylor
A Mutation Linked with Autism Reveals a Common Mechanism of Endoplasmic Reticulum Retention for the {alpha},beta-Hydrolase Fold Protein Family
J. Biol. Chem.,
April 7, 2006;
281(14):
9667 - 9676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Korza and M. Bochtler
Pseudomonas aeruginosa LD-Carboxypeptidase, a Serine Peptidase with a Ser-His-Glu Triad and a Nucleophilic Elbow
J. Biol. Chem.,
December 9, 2005;
280(49):
40802 - 40812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Pan, D. Gao, W. Yang, H. Cho, G. Yang, H.-H. Tai, and C.-G. Zhan
Computational redesign of human butyrylcholinesterase for anticocaine medication
PNAS,
November 15, 2005;
102(46):
16656 - 16661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Harel, J. L. Hyatt, B. Brumshtein, C. L. Morton, K. J. P. Yoon, R. M. Wadkins, I. Silman, J. L. Sussman, and P. M. Potter
The Crystal Structure of the Complex of the Anticancer Prodrug 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica Acetylcholinesterase Provides a Molecular Explanation for Its Cholinergic Action
Mol. Pharmacol.,
June 1, 2005;
67(6):
1874 - 1881.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|